US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

265.02

+2.030.77%

Pre-market: 265.020.00000.00%04:00 EDT

Volume:42.25K

Turnover:11.21M

Market Cap:2.88B

PE:31.01

High:266.64

Open:263.60

Low:263.60

Close:262.99

52wk High:274.99

52wk Low:173.98

Shares:10.85M

Float Shares:10.85M

Volume Ratio:1.48

T/O Rate:0.39%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.03

PE(LYR):7.02

Loading ...

Overview Company News Filings

Alkermes Releases Transcript of Q2 2026 Earnings Call

Alkermes sinks 5% to $50.05 following Q2 report

Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance

MT Newswires Live

Alkermes Q2 Sales $496.009M Beat $457.818M Estimate

Benzinga Earnings

Press Release: Alkermes Plc Reports Second Quarter 2026 Financial Results

Alkermes Plc : Piper Sandler Raises Target Price to $65 from $43

THOMSON REUTERS

Press Release: NEO Battery Reports Fiscal Year 2027 First Quarter Results

Oppenheimer would own Capricor Therapeutics into committee meeting

Pacira transitions PCRX-201 to a U.S.-based manufacturing process

Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Bruker (BRKR) and BrightSpring Health Services, Inc. (BTSG)

Top Growth Companies With Insider Ownership For July 2026

Simply Wall St.

Patrys flags investment risks and uncertainty around therapeutic drug development

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

Bruker to Release Q2 2026 Results, Host Earnings Webcast and Conference Call

Neogenomics is Maintained at Buy by Benchmark

AI Power Demand Reshapes Energy Investments, Brookfield Asset Management Acquires Storage Leader Aypa for $7 Billion

Corcept Therapeutics to Announce Second Quarter Financial Results

Corcept Therapeutics Schedules Second-quarter Results Conference Call

How DOJ Settlement Resolution and New PTEN CDx Launch Will Impact NeoGenomics (NEO) Investors

Simply Wall St.

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/FBT/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":265.02,"timestamp":1789588800000,"preClose":262.99,"halted":0,"volume":42247,"hourTrading":{"tag":"盘前","latestPrice":265.02,"preClose":265.02,"latestTime":"04:00 EDT","volume":1,"amount":265.02,"timestamp":1789632002243,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007718924673941871,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Pre-Mkt","change":2.03,"latestTime":"09-17 06:31:24 EDT","open":263.6,"high":266.64,"low":263.6,"amount":11212835.415800001,"amplitude":0.011559,"askPrice":272.14,"askSize":200,"bidPrice":259.89,"bidSize":200,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":265.02,"sharesOutstanding":11450002,"nav":263.09,"aum":2867681526.18,"bidAskSpread":0.001046,"preHourTrading":{"tag":"盘前","latestPrice":265.02,"preClose":265.02,"latestTime":"04:00 EDT","volume":1,"amount":265.02,"timestamp":1789632002243,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":265.02,"preClose":265.02,"latestTime":"19:30 EDT","volume":17,"amount":4505.34,"timestamp":1789601405208,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.4797444506447395,"impliedVol":0.1995,"impliedVolPercentile":0.344},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":1.4797444506447395,"shares":10850002,"dividePrice":0,"high":266.64,"amplitude":0.011559,"preClose":262.99,"low":263.6,"week52Low":173.975,"pbRate":"1.03","psRate":"693.68","week52High":274.99,"institutionHeld":0,"latestPrice":265.02,"eps":8.545272,"divideRate":0,"volume":42247,"delay":0,"ttmEps":8.545272,"open":263.6,"prevYearClose":206.52,"prevWeekClose":261.85,"prevMonthClose":267.15,"prevQuarterClose":247.89,"fiveDayClose":265.563,"twentyDayClose":260.7392,"sixtyDayClose":229.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654071550","title":"Alkermes Releases Transcript of Q2 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071550","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071550?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:17","pubTimestamp":1785244649,"startTime":"0","endTime":"0","summary":"Alkermes releases transcript of Q2 2026 earnings callAlkermes discussed Q2 2026 results on an earnings call attended by CEO Richard Pops, CFO Joshua Reed, CCO Todd Nichols, COO and incoming CEO Blair ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL35dZmZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4139","IBRN","ALKS","PSIL","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654007833","title":"Alkermes sinks 5% to $50.05 following Q2 report","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007833","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654007833?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:50","pubTimestamp":1785243027,"startTime":"0","endTime":"0","summary":"08:45 EDT Alkermes (ALKS) sinks 5% to $50.05 following Q2 report Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-sinks-5-to-50-05-following-q2-report-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-sinks-5-to-50-05-following-q2-report-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALKS","IBRN","MEDX","PSCH","FBT","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654100907","title":"Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2654100907","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654100907?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:42","pubTimestamp":1785238953,"startTime":"0","endTime":"0","summary":"Alkermes  reported break-even earnings for Q2 Tuesday, compared with earnings of $0.52 per share a year earlier.Analysts polled by FactSet expected a loss of $0.03.Total revenue for the quarter ended June 30 was $496 million, up from $390.7 million a year earlier.Analysts surveyed by FactSet expected $457.4 million.For 2026, Alkermes reiterated its total revenue guidance of $1.73 billion to $1.84 billion. Analysts polled by FactSet expected $1.81 billion.Shares of the company were up less than 1% in recent Tuesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALKS","PSIL","PSCH","FBT","BK4139","MEDX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006162","title":"Alkermes Q2 Sales $496.009M Beat $457.818M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006162","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006162?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:02","pubTimestamp":1785236572,"startTime":"0","endTime":"0","summary":"Alkermes (NASDAQ:ALKS) reported quarterly sales of $496.009 million which beat the analyst consensus estimate of $457.818 million by 8.34 percent.  This is a 26.97 percent increase over sales of $390.657 million the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60719288/alkermes-q2-sales-496-009m-beat-457-818m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS","IBRN","MEDX","PSCH","FBT","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006923","title":"Press Release: Alkermes Plc Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006923","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006923?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:00","pubTimestamp":1785236400,"startTime":"0","endTime":"0","summary":"DUBLIN--(BUSINESS WIRE)--July 28, 2026--Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended June 30, 2026. To view the detailed second quarter 2026 earnings press releas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","PSIL","IBRN","MEDX","ALKS","FBT","BK4139","ADHD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654502005","title":"Alkermes Plc : Piper Sandler Raises Target Price to $65 from $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2654502005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654502005?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:05","pubTimestamp":1785211555,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43T1LE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4139","PSCH","ALKS","IBRN","MEDX","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654202354","title":"Press Release: NEO Battery Reports Fiscal Year 2027 First Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654202354","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654202354?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:45","pubTimestamp":1785185100,"startTime":"0","endTime":"0","summary":"TORONTO, July 27, 2026 /CNW/ -- NEO Battery Materials Ltd.   , a low-cost, silicon-enhanced battery manufacturer enabling high-performance capabilities for drones, robotics, and physical AI, today announced its financial and operational results for the first quarter ended May 31, 2026. All amounts are in Canadian dollars unless otherwise specified.\"NEO is adding momentum from the increasing global requirements for high-performance, non-Chinese and Foreign Entities of Concern  battery products and solutions and is highly focused on expanding business opportunities with battery materials and cell developers, drone/unmanned aerial vehicle  manufacturers, and robotics companies,\" stated Mr. Spencer Huh, President & CEO of NEO. \"We are first steadily building out the Korean drone OEM pipeline with customers and qualified leads by implementing a collaborative approach from product development, testing/validation, and feedback-based optimization. Due to elevated interest in Korean, high-quali","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","LU0390134368.USD","LU2264538146.SGD","BK4096","ROK","UAV","LU0689626769.HKD","NEO","LU0154245673.USD","BK4608","BK4563","LU0154245756.USD","LU1894683348.USD","BK4607","BK4207","BK4585","BK4196","LU1064131342.USD","BK4121","KC","LU0472753341.HKD","LU1894683264.USD","BK4526","LU0106261612.USD","FBT","LU0057025933.USD","LU0511384066.AUD","BK4588","LU0012050646.USD","LU0289961442.SGD","CM","LU0124676726.USD","LU1988902786.USD","BK4116","BK4580","LU0069063385.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654045069","title":"Oppenheimer would own Capricor Therapeutics into committee meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654045069?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:20","pubTimestamp":1785162008,"startTime":"0","endTime":"0","summary":"After briefing documents for this Wednesday’s FDA advisory committee for deramiocel became available this morning, Oppenheimer analyst Leland Gersh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oppenheimer-would-own-capricor-therapeutics-into-committee-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oppenheimer-would-own-capricor-therapeutics-into-committee-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","BK4585","BBP","LABU","PBE","BBH","SBIO","CAPR","BK4139","BK4588","OPY","FBT","IBRN","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010362","title":"Pacira transitions PCRX-201 to a U.S.-based manufacturing process","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010362?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:10","pubTimestamp":1785154247,"startTime":"0","endTime":"0","summary":"Pacira (PCRX) announced that it has successfully transitioned PCRX-201, its investigational locally administered gene therapy for osteoarthritis of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pacira-transitions-pcrx-201-to-a-u-s-based-manufacturing-process-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pacira-transitions-pcrx-201-to-a-u-s-based-manufacturing-process-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GNOM","SYNB","EES","BK4588","FBT","PCRX","CNCR","LFSC","IBBQ","IBB","BK4007","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654124320","title":"Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Bruker (BRKR) and BrightSpring Health Services, Inc. (BTSG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654124320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654124320?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:40","pubTimestamp":1785152409,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on MannKind (MNKD), Bruker (BRKR) and BrightSpring He...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mannkind-mnkd-bruker-brkr-and-brightspring-health-services-inc-btsg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mannkind-mnkd-bruker-brkr-and-brightspring-health-services-inc-btsg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","TINY","BK4121","BK4588","LU1815336091.USD","BK4196","BK4585","BK4584","MNKD","BK4581","PTH","LU0128526141.USD","FBT","XBI","HCSG","BK4137","LU2468319806.SGD","BRKR","BTSG","LU0029874061.USD","XLV","PSCH","BK4139","LABU","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654901447","title":"Top Growth Companies With Insider Ownership For July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654901447","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654901447?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:05","pubTimestamp":1785150346,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a slight decline of 1.0%, though it remains up by 15% over the past year, with earnings forecasted to grow by 17% annually. In such an environment, companies that not only demonstrate growth potential but also have high insider ownership can be appealing as they often align management's interests with those of shareholders.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prta/prothena/news/top-growth-companies-with-insider-ownership-for-july-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prta/prothena/news/top-growth-companies-with-insider-ownership-for-july-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02525","BK4124","LU0566484027.USD","IREG","BK4532","LU2290526834.HKD","CBRS","XDAT","LU1861220033.SGD","BK4543","EQBK","STCE","IRE","HSAI","LU0353189763.USD","LU0154236417.USD","BK4561","SMYY","IE00B19Z9Z06.USD","APPX","UXIN","BK4182","LU0053671581.USD","FDIG","IBLC","LU2778985437.USD","BK4613","APP","BK4539","MNRS","BK4516","BK4600","EROC","LU0056508442.USD","KRMN","LU2250418816.HKD","KINS","LU2360107168.USD","WGMI","BK4007","BK4170","BK4563","BK4107","BK4139","SMCZ","IE00B19Z9P08.USD","CORT","SMCX","LU1559883803.SGD","BITQ","BK4588","LU1852331112.SGD","LU2360106780.USD","BK4187","BK4211","BK4585","SMCC","PSCH","BK4214","LU2476274720.SGD","DAPP","LU1861215975.USD","SMCI","UPSX","SMCL","BK4122","LU2087625088.SGD","IE00BZ9MQY76.HKD","FBT","BK4608","LU2476274308.USD","BK4023","LU0353189680.USD","BK4595","BKCH","BK4505","IE00B894F039.SGD","UPST","IREZ","BK4141","IREN","CLOD","SMCY","LU2063271972.USD","PRTA","IREX","LU0097036916.USD","BK4166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654672100","title":"Patrys flags investment risks and uncertainty around therapeutic drug development","url":"https://stock-news.laohu8.com/highlight/detail?id=2654672100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654672100?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:51","pubTimestamp":1785106305,"startTime":"0","endTime":"0","summary":"Patrys Limited ( ($AU:PAB) ) has provided an update. Patrys Limited has released a general information presentation outlining its activities in res...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/patrys-flags-investment-risks-and-uncertainty-around-therapeutic-drug-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/patrys-flags-investment-risks-and-uncertainty-around-therapeutic-drug-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PAB","LFSC","FBT","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654054554","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654054554","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654054554?lang=en_us&edition=fundamental","pubTime":"2026-07-25 22:50","pubTimestamp":1784991019,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Celldex (CLDX) with bullish sent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-celldex-cldx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","LABU","MEDX","BK4137","BK4588","LU0029874061.USD","LU0128526141.USD","XBI","ALKS","IBRN","CLDX","BK4581","BK4139","HCSG","BK4585","PSIL","XLV","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654032304","title":"Bruker to Release Q2 2026 Results, Host Earnings Webcast and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2654032304","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654032304?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:01","pubTimestamp":1784923272,"startTime":"0","endTime":"0","summary":"Bruker to release Q2 2026 results, host earnings webcast and conference callBruker schedules Q2 2026 results release before the market opens on Aug. 4, 2026.Conference call webcast set for Aug. 4, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDLpWK38:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","BRKR","BK4121","LU0757428866.USD","TINY","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653222082","title":"Neogenomics is Maintained at Buy by Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2653222082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653222082?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:50","pubTimestamp":1784897400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NEO/analyst-ratings(END) Dow Jones NewswiresJuly 24, 2026 08:50 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","BK4121","FBT","LU0012050646.USD","NEO","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173784170","title":"AI Power Demand Reshapes Energy Investments, Brookfield Asset Management Acquires Storage Leader Aypa for $7 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1173784170","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173784170?lang=en_us&edition=fundamental","pubTime":"2026-07-23 08:14","pubTimestamp":1784765669,"startTime":"0","endTime":"0","summary":"Brookfield Asset Management Ltd (NYSE: BAM) has agreed to acquire battery storage developer Aypa Power for $7 billion, including debt. This move comes as demand surges from companies fueling the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1171","ANEW","BK4585","BK4135","FBT","HEAT","BRKR","TINY","LU1815336091.USD","CHAT","BK4121","ARTY","PBW","QTOC","AIPO","02570","BK4588","BAM","LU0757428866.USD","ACES","VTHR","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653799128","title":"Corcept Therapeutics to Announce Second Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2653799128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653799128?lang=en_us&edition=fundamental","pubTime":"2026-07-23 06:00","pubTimestamp":1784757602,"startTime":"0","endTime":"0","summary":"BRIEF-Corcept Therapeutics To Announce Second Quarter Financial ResultsJuly 22 (Reuters)-Corcept Therapeutics IncCORT.O:CORCEPT THERAPEUTICS TO ANNOUNCE SECOND QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALLSource text:ID:nBw7GQVldaFurther company coverage:CORT.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA2QJWLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","LU1559883803.SGD","FBT","BK4532","BK4007","PSCH","CORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653798193","title":"Corcept Therapeutics Schedules Second-quarter Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2653798193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653798193?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:05","pubTimestamp":1784750729,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics schedules second-quarter results conference callCorcept set July 29, 2026 to report second-quarter financial results, issue a corporate update, host a conference call at 5 p.m. ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL1V8Pdx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","FBT","LU1559883803.SGD","BK4007","CORT","PSCH","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653013712","title":"How DOJ Settlement Resolution and New PTEN CDx Launch Will Impact NeoGenomics (NEO) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2653013712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653013712?lang=en_us&edition=fundamental","pubTime":"2026-07-21 22:27","pubTimestamp":1784644055,"startTime":"0","endTime":"0","summary":"In June 2026, NeoGenomics finalized a civil settlement with the U.S. Department of Justice, agreeing to pay US$9,813,260 plus interest to resolve an investigation into consulting arrangements, having previously reserved US$11,200,000 for potential liabilities.\nSeparately, the company launched PTEN IHC CDx, the first FDA-approved immunohistochemistry companion diagnostic for PTEN-deficient prostate adenocarcinoma, expanding its role in targeted prostate cancer care.\nWe’ll now examine how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-doj-settlement-resolution-and-new-pten-cdx-launch-will-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/how-doj-settlement-resolution-and-new-pten-cdx-launch-will-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0106261612.USD","ISBC","FBT","BK4121","PTEN","BK4092","BK4211","BK4196","NEO","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277231","title":"Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277231?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:34","pubTimestamp":1784637260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0YI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","PSIL","PSCH","BK4139","FBT","ALKS","IBRN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}